Skip to content

Neurofeedback: An effective treatment for impulsivity and addiction in forensic psychiatric patients?

Reduction of impulsivity and drug-seeking behaviour in forensic psychiatric patients through neurofeedback

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24938
Enrollment
60
Registered
2015-07-15
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Forensic inpatient treatment, substance abuse disorder, neurofeedback, impulsivity, cued Go/No-Go task, BIS-11, Desire for alcohol questionnaire (DAQ). Forensische psychiatrie, TBS, middelenafhankelijkheid, verslaving, neurofeedback, impulsiviteit, cued Go/No-Go taak, BIS-11, DAQ (DAQ).

Interventions

Participants in the intervention + TAU condition will receive 20 neurofeedback sessions, each lasting for approximately 40 minutes, in which EEG activity is measured across delta (0,5-3,5 hz), theta (

Sponsors

FPC Dr. S. van Mesdag, Helperlinie 2, 9722 AZ Groningen University of Tilburg, Warandelaan 2, 5037 AB Tilburg FPC De Kijvelanden, Kijvelandsekade 1, 3172 AB Portugaal.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Under inpatient forensic custody 2) Age 18 or older 2) Official DSM-IV-TR AS-I diagnosis of substance abuse disorder or substance dependency 3) Ability to give informed consent 4) Able to understand, speak, read and write the Dutch language sufficiently 5) Able and willing to comply to research requirements, such as attending appointments, being able to sit relatively still for 40 minutes.

Exclusion criteria

Exclusion criteria: 1) Acute psychosis or other severe, current psychiatric symptoms such as extreme manic, suicidal and/or aggressive symptoms 2) Acquired/congenital brain impairments, such as epilepsy 3) Visual and/or auditory impairments where participants are unable to follow neurofeedback-training

Design outcomes

Primary

MeasureTime frame
Resting-state EEG Participants will undergo a 21-channel EEG with Nexus-32 hardware and Biotrace+ software 19 standard channels including right and left mastoid locations) with a sampling rate of 512 samples per second. Four separate flat type electrodes will be used to measure horizontal and vertical eye-movements. Barrat impulsivity Scale -11 The Barrat Impulsivity Scale measures behavioural and personality construct of impulsivity across three factors: attentional, motor and nonplanning. It consists of 30 items scored on 4 point scale ranging from rarely/never to almost always/always. Cued Go/No-Go task The cued Go/No-Go task is a continuous performance test, measuring impulse control by the ability to inhibit prepotent responses. DAQ The desire for alcohol questionnaire (DAQ) is a self-report questionnaire assessing the desire to drink alcohol at the moment of assessment. It consists of four factors: intention to drink, desire to consume alcohol, anticipation of positive outcome from drinking, anticipation of relief of negative effect from withdrawal. A short-form of the questionnaire will be used, consisting of 14 items.

Secondary

MeasureTime frame
Actual drug-use Number of urine samples collected will be counted, as will be positive (meaning drug-use in the period of time since last drug test) and negative (meaning no drug-use since last testing) outcome scores. Corresponding with clinical policy, refusal to undergo urine-analysis will be scored as a positive result. Covariates (demographic characteristics, psychopathology, time in forensic treatment, actual drug use during the past 24 months, medication, clinical-risk assessment score, routine outcome measurements) will be collected through file information.

Contacts

Public ContactSandra Fielenbach

Helperlinie 2

s.fielenbach@fpcvanmesdag.nl050-5221221

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)